Revenio Group Oyj (FRA:R0V)

Market Cap	419.30M -32.5%
Revenue (ttm)	109.85M +5.8%
Net Income	17.41M -5.9%
EPS	0.65 -5.9%
Shares Out	n/a
PE Ratio	24.08
Forward PE	18.95
Dividend	0.40 (2.52%)
Ex-Dividend Date	Apr 11, 2025

Volume	n/a
Average Volume	0
Open	15.62
Previous Close	15.68
Day's Range	15.62 - 15.62
52-Week Range	15.62 - 29.35
Beta	n/a
RSI	33.55
Earnings Date	Apr 28, 2026

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used for mea...

• Industry: Computer Integrated Systems Design
• Founded: 2001
• Employees: 243
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: R0V

Financial Performance

In 2025, Revenio Group Oyj's revenue was 109.85 million, an increase of 5.80% compared to the previous year's 103.82 million. Earnings were 17.41 million, a decrease of -5.87%.